Sexuality



Sexuality


Margaret Chamberlain Wilmoth



INTRODUCTION

Humans are sexual beings from birth until death. Sexuality is an integral aspect of our personalities and is more than sexual contact and the ability to reach sexual satisfaction. Sexuality includes views of ourselves as male or female, feelings about our bodies, and the ways we communicate verbally and nonverbally our comfort about ourselves to others. It also includes the ability to engage in satisfying sexual behaviors alone or with another. Sexuality does not end when one reaches a certain age, nor does it end with the diagnosis of a chronic illness. In fact, sexuality and intimacy may become more important after such a diagnosis as a way of reaffirming human connection, aliveness, and continued desirability and caring. Sexuality is a critical aspect of quality of life that, unfortunately, is often ignored by healthcare professionals.

This chapter briefly reviews standards of nursing practice as they relate to sexuality, sexual physiologic functioning, alterations in sexuality caused by common chronic illnesses and their treatments, and nursing interventions. This chapter also provides nurses with suggestions for ways to incorporate discussions of sexuality into their practice.










Table 11-1 Definitions

















Sexuality


Everything that makes one a man or woman, including the need for touch, feelings about one’s body, the need to connect with another human being in an intimate way, interest in engaging in sexual behaviors, communication of one’s feelings and needs to one’s partner, and the ability to engage in satisfying sexual behaviors


Sexual behaviors


Specific activities used to obtain release of sexual tension alone or with another in order to achieve sexual satisfaction; refers also to the multiple ways one verbally and nonverbally communicates sexual feelings and attitudes to others


Sexual functioning


The physiologic component of sexuality, including human sexual anatomy, the sexual response cycle, neuroendocrine functioning, and lifecycle changes in sexual physiology


Sexual dysfunction


Characterized by disturbances in the processes of the sexual response cycle or by pain associated with sexual intercourse; is a DSM-IV-TR diagnosis and should not be used by nurses unless they are specially trained in treating sexual dysfunctions


Sources: Wilmoth, M. C. (2009). Sexuality. In C. Burke (Ed.), Psychosocial dimensions of oncology nursing care (2nd ed., pp. 101-124). Pittsburgh: Oncology Nursing Press. American Psychological Association. (2000). Diagnostic and statistical manual of mental disorders DSM-IV-TR (4th ed., text revision). Washington, DC: Author.



Standards of Practice

Standards of practice confer both a legal standard of practice as well as an ethical responsibility that nurses adhere to in their practice of nursing (Andrews, Goldberg, & Kaplan, 1996). Standards of practice for the profession, published by the American Nurses Association (ANA) (2010), include six standards of care that encompass significant actions taken by nurses when providing care to their clients. These standards include the components of the nursing process. These standards also assume that all relevant healthcare needs of the client will be assessed and appropriate care provided, including needs regarding sexuality.

Specialty organizations have derived standards of nursing practice from those published by the ANA that are specific to their practice. For example, the Oncology Nursing Society (2004) published nursing practice standards that specifically identified sexuality as one potential area of client concern. These standards include both assessment criteria and outcome criteria. Nurses who care for cancer patients then are expected to follow each of these standards in the provision of patient care (Table 11-2).

Nurses and physicians are legally obligated to ensure that clients have the necessary information to make decisions regarding treatment. The provision of informed consent also requires that all risks, benefits, and side effects of diseases and their treatments be provided to clients as they choose treatments for any illness. This includes information about potential sexual side effects of proposed treatments. Failure to provide this information could potentially lead to legal action by the client.


The Sexual Response Cycle and Sexual Physiology

There are two frameworks commonly used to describe what is called the “sexual response
cycle.” The first, proposed by Dr. William Masters and Virginia Johnson (1966), is a fourstage model of sexual response of the male and female. The four phases of the Masters and Johnson (1966) model are excitement, plateau, orgasm, and resolution. The excitement stage causes an increase in the heart rate and vasocongestion to the penis. This is accompanied by lengthening and widening of the vagina, elevation of the cervix and uterus, and initial swelling of the labia minora (Guyton & Hall, 2006; Masters & Johnson, 1966). These changes are caused by vasocongestion and are secondary to a parasympathetic response mediated to S2 and S4 through the pudendal nerve and sacral plexus (Guyton & Hall, 2006).








Table 11-2 Oncology Nursing Society Statement on the Scope and Standards of Oncology Nursing Practice




















Standard I Assessment


Standard III Outcome Identification


The oncology nurse systematically and continually collects data regarding the health status of the patient.


The oncology nurse identifies expected outcomes individualized to the patient.


Measurement Criteria


Measurement Criteria


The oncology nurse collects data in the following 14 high-incidence problem areas that may include but are not limited to: sexuality.


The oncology nurse develops expected outcomes for each of the 14 high-incidence problem areas within a level consistent with the patient’s physiology, psychosocial and spiritual capacities, cultural background, and value system. The expected outcomes include but are not limited to sexuality. The patient and/or family:


1. Past and present sexual patterns and expression


2. Effects of disease and treatment on body image.


3. Effects of disease and treatment on sexual function.


4. Psychological response of patient and partner to disease and treatment.


1. Identifies potential or actual changes in sexuality, sexual functioning, or intimacy related to disease and treatment.


2. Expresses feelings about alopecia, body image changes, and altered sexual functioning.


3. Engages in open communication with his or her partner regarding changes in sexual functioning or desire, within cultural framework.


4. Describes appropriate interventions for actual or potential changes in sexual function.


5. Identifies other satisfying methods of sexual expression that provide satisfaction to both partners, within cultural framework.


6. Identifies personal and community resources to assist with changes in body image and sexual functioning.


Source: Oncology Nursing Society. (2004). Statement on the scope and standards of oncology nursing practice. Pittsburgh, Author.



The second stage is the plateau stage, which is an increased state of arousal causing the heart rate and blood pressure to increase, with a subsequent increase in respiratory rate (Katz, 2007). The third stage is the orgasm, the phase of maximal muscular contraction (male ejaculation, and female pelvic muscle contraction), with a peak of respirations and heart rate, and a subjective feeling of intense pleasure that radiates throughout the body (Katz, 2007). Impending orgasm is determined by the presence of an intense color change in the labia minora in women and full elevation of the scrotal sac to the perineal wall in men, all a result of intense vasocongestion (Masters & Johnson, 1966). Orgasm is mediated by the sympathetic nervous system and is the physical release and peak of pleasurable expression, followed by relaxation (Guyton & Hall, 2006). The sympathetic nerves between T12 and L2 control ejaculation (Koukouras et al., 1991). The intensity of orgasm in women is dependent upon the duration and intensity of sexual stimulation.

The final stage is resolution, when vasocongestion resolves and the body returns to its normal nonaroused state (Katz, 2007). Men also have what is referred to as a “refractory period,” which is the period within which the male is unable to achieve an erection satisfactory for penetration. This period of time is age and health-status dependent (Masters & Johnson, 1966).

Physical changes that occur in both men and women as a result of sexual stimulation are vasocongestion and myotonia. Vasocongestion occurs in the penis in men and in the labia in women, and is an essential requirement for orgasm and subsequent sexual satisfaction. Myotonia refers to the involuntary muscular contractions that occur throughout the body during sexual response (Kolodny, Masters, Johnson, & Biggs, 1979).

The second framework is from Kaplan. Kaplan’s (1979) modification of the sexual response cycle includes aspects of sexual physiology involving the prelude to sexual activity as well as the consequences of sexual activity. These three phases are desire, arousal, and orgasm. Desire is the prelude to engaging in satisfying sexual behaviors and is the most complex component of the sexual response cycle. Desire is often affected by factors such as anger, pain, and body image, as well as disease processes and medications (Kaplan, 1979). When sexual stimuli are perceived by women, they are processed physiologically and physically, leading to subjective feelings of arousal and a responsive feeling of desire (Katz, 2007). This may explain why psychogenic factors can be a determinant cause of male and female sexual dysfunction.

Arousal, manifested by erection in males, is mediated by the parasympathetic nervous system and is the result of either psychic or somatic sexual stimulation (Masters & Johnson, 1966). Alternately, activation of the sympathetic nervous system will lead to loss of an erection through vasoconstriction. It was previously thought that an analogous process of parasympathetic nervous system stimulation led to arousal in women. However, evidence suggests that it is stimulation of the sympathetic nervous system (SNS) that is responsible for female arousal (Meston, 2000). Data also suggest that stimulation of the SNS may enhance arousal in women with low sexual desire (Meston & Gorzalka, 1996) and that induction of relaxation may negatively affect arousal (Meston, 2000).

Although many women suggest that the Gräfenberg spot (G-spot) plays an important role in their sexuality, the existence of this sensitive
area remains open for verification (Hines, 2001). The G-spot is purportedly located in the anterior wall of the vagina, about halfway between the back of the pubic bone and the cervix along the course of the urethra (Ladas, Whipple, & Perry, 1982). When stimulated, this tissue swells from the size of a bean to greater than a half dollar (Ladas et al., 1982). Stimulation of this area appears to cause a different orgasmic sensation, and it is hypothesized that this response is mediated by the pelvic nerve, causing the uterus to contract and descend against the vagina rather than elevate, as with stimulation mediated by the pudendal nerve (Ladas et al., 1982). Approximately 40% of women will experience expulsion of a fluid upon orgasm caused by G-spot stimulation (Darling, Davidson, & Conway-Welch, 1990). Research suggests that this is a prostatic-like fluid that is released during orgasm (Zaviacic & Whipple, 1993; Zaviacic & Ablin, 2000). Belief that this is not urine but a normal release of fluid that occurs during sexual response may lead to a reduction in embarrassment for many women.

The neurohormonal system influences sexual functioning through its effect on hormone production. The hypothalamic-hypophysial portal system plays an important role in sexual functioning in both genders through production of gonadotropin-releasing hormone (GnRH) and subsequent stimulation of gonadotropin production by the anterior pituitary gland. The anterior pituitary gland secretes six hormones, two of which play an essential role in sexual functioning. Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) control growth of the gonads and influence sexual functioning. In men, LH influences production of testosterone by the Leydig cells in the testes through a negative feedback loop (Guyton & Hall, 2006). Production of GnRH is reduced, once a satisfactory level of testosterone has been attained. A negative feedback loop also exists in the woman, although it is much more complex, given the concurrent production of estrogen and progesterone by the ovary and the production of androgens by the adrenal cortex.

Psychic factors appear to play a larger role in the sexual functioning in women than in men, particularly in relation to sexual desire. Multiple neuronal centers in the brain’s limbic system transmit signals into the arcuate nuclei in the mediobasal hypothalamus. These signals modify the intensity of GnRH release and the frequency of the impulses (Guyton & Hall, 2006). This may explain why desire in women is more vulnerable to emotions and distractions than it is in men.

Aging affects the sexual response cycle in predictable ways, but it does not signal the end of sexuality. In fact, the old adage, “use it or lose it,” is applicable to continued sexual activity throughout life (Masters & Johnson, 1981). The general impact of aging on the sexual response cycle is a slower, less intense sexual response (Lindau, Schumm, Gaumann, Levinson, O’Muircheartaigh, & Waite, 2007). The frequency of sexual activity in earlier years is predictive of frequency as one ages. The quality of the sexual relationship appears to be the greatest influence on the frequency and satisfaction of sexual activity (Masters & Johnson, 1981). As in younger adults, the quality of communication in a relationship, degree of mutual intimacy, and level of commitment to the relationship are vital to a satisfying sexual relationship and to achieving sexual satisfaction.

In clients aged 60 or older, organic factors are the most important determinant of erectile dysfunction (Corona et al., 2007). The frequent
comorbidity of multiple metabolic and hemodynamic abnormalities in aging clients can substantially increase the incidence and progression of atherosclerotic lesions, leading to vascular forms of erectile dysfunction (Corona et al., 2007). Masters and Johnson (1966) found that in men between 51 and 90 years of age, the time to achieve erection was two to three times longer than in younger men. Achieving erection also required more tactile stimulation than in younger years. However, once achieved, older men can maintain a full erection for a longer period before ejaculation. Scrotal vasocongestion is reduced, with a subsequent decrease in testicular elevation. Basal and dynamic peak cavernosal velocity was shown to be reduced in older patients via Doppler ultrasound penile examination (Corona et al., 2007). The ability to attain orgasm is not impaired with aging, but there is an overall decrease in myotonia and fewer penile and rectal sphincter contractions. There is an increase in time from hours to days before older men can achieve another erection once they have ejaculated and achieved an orgasm (refractory period).

Women also experience sexual response cycle changes as they age, primarily after completing the menopausal transition. Common complaints include decreased desire, dry vagina, and difficulty attaining orgasm (Lindau et al., 2007). Vaginal changes include a thinning of the mucosa, with a decrease in vaginal lubrication. In women who abstain from sexual intercourse, narrowing and stenosis of the introitus and vaginal vault can occur (Leiblum & Segraves, 1989). Older women experience a decrease in the vasocongestion of the labia and other genitalia analogous to the decrease in penile tumescence experienced by men. Orgasm in sexually active women is not impaired; however, there is some decrease in the degree of myotonia experienced. Intense orgasm may lead to involuntary distension of the external meatus, leading to an increase in frequency of urinary tract infections in older women.


SEXUALITY AND CHRONIC ILLNESS

The presence of a chronic illness affects all aspects of an individual’s life, including their sexuality. There are numerous chronic illnesses, and discussion of the impact of each on sexuality is beyond the scope of this chapter. Therefore, this chapter is limited to a brief discussion of the effects of coronary artery disease, diabetes mellitus, cancer, and multiple sclerosis on sexuality.


Coronary Artery Disease

The heart is linked to romance and to the soul, so any threat to cardiac functioning is emotionally linked to matters of the self, sexuality, and intimacy. Cardiovascular disease, including coronary artery disease (CAD) and stroke, causes more death in both genders and all racial and ethnic groups in the United States than any other disease (Centers for Disease Control and Prevention, 2004). More men and women than ever before are living longer and continue to lead productive lives after experiencing a myocardial infarction (MI); however, recent data suggest that women experience a lower degree of quality of life than men (Agewall, Berglund, & Henareh, 2004; Svedlund & Danielson, 2004). Therefore, having adequate and accurate knowledge about sexuality post-diagnosis may have a positive impact crucial to individuals’ self-concept, to their sexuality, and to their sexual relationships.

The consensus study from the Second Princeton Consensus Conference collaborates
and clarifies the risk stratification algorithm that was developed by the first Princeton Consensus Panel to evaluate the degree of cardiovascular risk associated with sexual activity for men with varying degrees of cardiovascular disease (Kostis et al., 2005). The algorithm emphasizes the importance of risk factor evaluation and management for all patients with erectile dysfunction (ED). The relative safety in which clients can engage in sexual activity is dependent on their degree of cardiac disease. This panel recommended a classification system that would stratify clients into a risk category based on the extent of their cardiac disease. These categories and management recommendations are found in Table 11-3. Patients with less than three major risk factors for cardiovascular disease (age, hypertension, diabetes mellitus, cigarette smoking, dyslipidemia, sedentary lifestyle, and family history of premature coronary artery disease) are generally at low risk for significant cardiac complications from sexual activity or the treatment of sexual dysfunction (Kostis et al., 2005). Clients whose cardiac conditions are uncertain, as well as those with multiple risk factors, require further testing or evaluation before
resuming sexual activity (Kostis et al., 2005). Patients with a history of MI (> 2 weeks and < 6 weeks) may be at somewhat greater risk for coitus-induced ischemia and reinfarction, as well as malignant arrhythmias (Kostis et al., 2005). The level of risk associated within this time period post-MI can be assessed with an exercise stress test.








Table 11-3 Management Recommendations Based on Graded Cardiovascular (CV) Risk Assessment























Grade of Risk


Categories of CVD


Management


Low risk


Asymptomatic, 6 weeks; mild valvular disease, LVD/CHF (NYHA class I); patients with pericarditis, mitral valve prolapse, or atrial fibrillation with controlled ventricular response should be managed on an individualized basis


Primary care management; consider all firstline therapies; reassess at regular intervals


Intermediate risk


Three major risk factors for CAD; moderate, stable angina; recent MI (> 2 weeks, < 6 weeks); LVD/CHF (NYHA class II); noncardiac sequelae of atherosclerotic disease (e.g., CVA, PVD)


Specialized CV testing; restratification into high or low risk based on results of CV testing


High risk


Unstable or refractory angina; uncontrolled hypertension; LVD/CHF (NYHA class III/IV); recent MI (< 2 weeks), CVA; high-risk arrhythmias; obstructive hypertrophic and other cardiomyopathies; moderate-severe valvular disease


Priority referral for specialized CV management; treatment for sexual dysfunction deferred until cardiac condition stabilized and dependent on specialist recommendations; sexual activity should be deferred until a patient’s cardiac condition has been stabilized by treatment or a decision has been made by a specialist


CAD, coronary artery disease; CHF, congestive heart failure; CVA, cerebrovascular accident (stroke); CVD, cardiovascular disease; LVD, left ventricular dysfunction; NYHA, New York Heart Association; PVD, peripheral vascular disease. Source: From DeBusk, R., Drory, Y., Goldstein, I., Jackson, G., Kaul, S., & Kimmel, S. E. (2000). Management of sexual dysfunction in patients with cardiovascular disease: Recommendations of the Princeton Consensus Panel. The American Journal of Cardiology, 86 (2), 175-181.


Kostis, J. B., Jackson, G., Rosen, R., Barrett-Connor, E., Billups, K., Burnett, A. L. et al. (2005). Sexual dysfunction and cardiac risk (the second Princeton Consensus Conference). American Journal of Cardiology, 96 (12B), 85M-93M.


Counseling of all clients regarding lifestyle changes and activity restrictions should begin as soon as the client is stabilized. Discussions regarding sexual activity should be included in the counseling. Potential fear of cardiac arrest during sexual activity should be eradicated as soon as possible by assuring clients and their partners that this risk is only 1.2% and that sex accounts for only 0.5-1.0% of all acute coronary incidents (DeBusk, 2000).

Recent reports continue to validate the appropriateness of the stair-climbing tolerance test for successful return to sexual activity after 6 weeks post-MI. Sexual activity conceptualized simply as arousal is unassociated with physical exertion. It is not until exertion is coupled with arousal that energy expenditure occurs. Data indicate that the man in the top position results in greater responses of heart rate and maximum volume of oxygen (VO2), and thus greater energy expenditure that may or may not reflect both heightened arousal and exertion. If sexual activity is conceptualized as exertion, then the capacity to climb two flights of stairs without limiting symptoms is a clinical benchmark of exercise tolerance and subsequent ability to engage in sexual activity without symptoms (DeBusk, 2000).

Depression has been indicated as a psychological cause of sexual dysfunction and may increase the risk of cardiac mortality in both genders (Roose & Seidman, 2000). A discrepancy between male and female sexual desire, which could disturb relationships, can be observed in many aging couples (Corona et al., 2007). Roose and Seidman (2000) indicate that the male client with ischemic heart disease who is depressed is also likely to have erectile difficulties. This is also a predisposing factor for other adverse cardiac events. Therefore, it appears prudent that all post-MI clients be evaluated for depression and receive appropriate therapy. A wide body of evidence supports the hypothesis of a strong association between depression and ED (Corona et al., 2007). The age-dependent increased use of psychotropic drugs such as antidepressants and antipsychotics may play an important role in ED in older clients (Corona et al., 2007).

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 29, 2016 | Posted by in NURSING | Comments Off on Sexuality

Full access? Get Clinical Tree

Get Clinical Tree app for offline access